Is a complete KPRX research report available?

No complete published report is available for Kiora Pharmaceuticals, Inc. (KPRX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Kiora Pharmaceuticals, Inc. (KPRX)

NASDAQ: KPRX · USD

$2.55

+0.05 (+2.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first KPRX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	11.3M
Net income (ttm)	-11.1M
EPS (ttm)	-$2.66
Shares out	4.4M
Volume	130,637
Beta	-0.39

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -11.1M
EPS (ttm): -$2.66
Market cap: 11.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All KPRX indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001372514
Company name	Kiora Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	49721T507
Employees	13
Employees Change	1%
Employees Change Percent	8.33
Enterprise value	$-2.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US49721T5074
Last refreshed	2026-07-25
Market cap	$11.3M
Market cap category	Nano-Cap
Price	$2.55
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	KPRX
Website	https://www.kiorapharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-97.86%
FCF yield	-93.21%
P/B ratio	0.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-4M
Net Income	$-11.1M
Net Income Growth Years	0%
Profit Per Employee	$-850,781
ROA	-22.41
Roa5y	-22.19
ROCE	-70.6
ROE	-58.78
Roe5y	-77.98
ROIC	-32.45

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-57.51%
Cagr1y	-18.02%
Cagr3y	-22.89%
Cagr5y	-70.74%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$21.2M
Cash	$13.9M
Current Assets	$18.7M
Current Liabilities	$2.8M
Debt	$373,586
Debt Equity	$0.03
Equity	$13.9M
Interest Coverage	-651.8
Liabilities	$7.3M
Long Term Assets	$2.5M
Long Term Liabilities	$4.5M
Net Cash	$13.5M
Net Cash By Market Cap	$119
Net Cash Growth	-43.63%
Net Debt Equity	$-0.97
Tangible Book Value	$13.9M
Tangible Book Value Per Share	$3.49
WACC	2.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.68
Net Working Capital	$2.2M
Quick ratio	6.19
Working Capital	$15.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.2%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.98%
1Y total return	-18.01%
200-day SMA	2.31
3Y total return	-54.15%
50-day SMA	2.59
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.79%
All Time High	189,000.2
All Time High Change	-100%
All Time High Date	2015-07-22
All Time Low	1.77
All Time Low Change	44.48%
All Time Low Date	2025-11-25
ATR	0.11
Beta	-0.39
Beta1y	1.51
Beta2y	1.18
Ch YTD	29.44
High	2.6
High52	3.13
High52 Date	2025-07-24
High52ch	-18.53%
Low	2.28
Low52	1.77
Low52 Date	2025-11-25
Low52ch	44.48%
Ma50ch	-1.51%
Price vs 200-day SMA	10.25%
RSI	49.87
RSI Monthly	31.33
RSI Weekly	54.42
Sharpe ratio	-0.09x
Sortino ratio	-0.04
Total Return	1.2%
Tr YTD	29.44
Tr1m	-1.92%
Tr1w	-3.04%
Tr3m	6.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.62
Operating Income	$-9.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,299,538%
Float Percent	97.01%
Shares Insiders	2.99%
Shares Institutions	10.54%
Shares Out	4,431,940
Shares Qo Q	0.11%
Shares Yo Y	-1.2%
Short Float	0.17%
Short Ratio	0.27
Short Shares	0.16

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-11.5M
Average Volume	22,315.3x
Bv Per Share	3.49
CAPEX	$-115,807
Ch10y	-99.98
Ch1m	-1.92
Ch1w	-3.04
Ch1y	-18.01
Ch3m	6.25
Ch3y	-54.15
Ch5y	-99.79
Ch6m	20.28
Change	2%
Change From Open	2
Close	2.5
Days Gap	0
Depreciation Amortization	35,046
Dollar Volume	333,124.4
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-13M
EBITDA	$-13M
EPS	$-2.66
F Score	2
FCF	$-10.5M
FCF EV Yield	479.47x
FCF Per Share	$-2.38
Financing CF	264,813
Fiscal Year End	December
Founded	1,998
Income Tax	$-1.4M
Investing CF	17,154,845
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2024-06-11
Last Split Type	Reverse
Last10k Filing Date	2026-03-25
Ma150	2.32
Ma150ch	9.87%
Ma20	2.56
Ma20ch	-0.2%
Net CF	7,184,942
Next Earnings Date	2026-08-07
Open	2.5
Optionable	No
Position In Range	84.37
Post Close	2.55
Postmarket Change Percent	-0.78
Postmarket Price	$2.53
Ppne	388,301
Price Date	2026-07-24
Ptbv Ratio	0.81
Relative Volume	5.85x
Share Based Comp	961,130
Tr6m	20.28%
Us State	California
Volume	130,637

Kiora Pharmaceuticals, Inc. (KPRX)

Coverage state: Market snapshot only — no published research

Generate the first KPRX analysis

Price

Financial snapshot

Fair-value bridge

Latest news · KPRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KPRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on KPRX

Frequently asked questions